CBI Scene Blog

Direct-to-Patient, Remote Trials, Site-less Trials, and Digital Trials Different Ways of Saying 'Trial Success' and 'Positive Patient Experiences'

Posted by Evanna Payen on Jul 16, 2018 10:50:58 AM

CBI’s Direct-to-Patient Clinical Trials conference will address all these leading groundbreaking trials and help you keep pace with a rapidly changing frontier regardless of what terminology you utilize. For a quick look at how site-less, remote, digital, and direct-to-patient trials cover the same ground check out the trial definitions from industry leaders below.

Read More

Topics: clinical trial supplies, clinical supply chain, Clinical Trials, Direct-to-Patient, Remote Trials, Patient Centric Trials, siteless trials, digital trials

Q&A with Matthew Amsden, Founder and CEO of ProofPilot

Posted by Evanna Payen on Jun 25, 2018 1:03:06 PM

It's Gay Pride Month and events across the world celebrate wins and bring attention to issues that still need attention. The community still struggles with health disparities and the HIV epidemic. CBI Conference Producer, Trevor Sosvielle, sat down with Matthew Amsden, CEO of ProofPilot to chat about his early work in HIV prevention trials. He tells explains how these experiences helped shape ProofPilot and its patient-centric clinical trial approach.

Read More

Topics: Clinical Trials, Direct-to-Patient, Remote Trials, Patient Centric Trials

How to Align Management with Functional Areas of R&D

Posted by Evanna Payen on Apr 11, 2018 9:39:01 AM

While it's an issue that's not limited to the pharmaceutical industry, miscommunication between the "doers" - those actually performing clinical trials - and the "planners," who set and monitor the budget, is particularly prominent. While research and development in a non-pharmaceutical business can often be put on indefinite hold while funding is secured, clinical trials don't share that luxury. Variables such as timing, resources, and the ability to make adjustments if obstacles arise are freedoms all crucial to a given trial's success. This means, in turn, that "holding" isn't really a viable option. So how can the behind-the-scenes program teams work in tandem with those on the front lines?

Read More

Topics: Clinical, Clinical Trials, Budgeting, Forecasting, CROS, Sites, Operations, Finance, Research and Development

Subscribe to CBI Scene Blog

Latest Posts